AstraZeneca, EU reach settlement on delivery of COVID-19 vaccines

The European Commission and AstraZeneca said on Friday they had reached a settlement on delivering remaining COVID-19 vaccine doses by the British drugmaker and also ended pending litigation in Brussels

The settlement clears a major overhang for AstraZeneca, whose cheap and easily transportable vaccine has faced several setbacks, including the lawsuit and worries about possible side-effects. It also allows the European Union to speed up inoculations amid shortages. Under the settlement AstraZeneca has committed to deliver 60 million doses of its vaccine, Vaxzevria, by the end of the third quarter this year, 75 million by the end of the fourth quarter and 65 million by the end of the first quarter of 2022.